{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:26:06Z","timestamp":1786119966291,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Investigative Radiology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/rli.0b013e3182218dc3","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T07:43:23Z","timestamp":1306482203000},"page":"663-671","source":"Crossref","is-referenced-by-count":55,"title":["Safety of Gadobutrol, a New Generation of Contrast Agents"],"prefix":"10.1097","volume":"46","author":[{"given":"Matthias","family":"Voth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josy","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Investigative Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLI.0b013e3182218dc3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:27:30Z","timestamp":1786044450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004424-201111000-00001"}},"subtitle":["Experience From Clinical Trials and Postmarketing Surveillance"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":0,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.1097\/rli.0b013e3182218dc3","relation":{},"ISSN":["0020-9996"],"issn-type":[{"value":"0020-9996","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}